Tag Archives: 54gene

54gene Closes $25M Series B to Advance Global Drug Discovery Capabilities

Cathay Africinvest Innovation leads round as company expands precision medicine capabilities across the African continent 54gene, the health technology company advancing African genomics research for improved global health outcomes, has secured $25M in a Series B round, led by Cathay AfricInvest Innovation Fund. The round also included participation from Adjuvant Capital, KdT Ventures, Plexo Capital, […]

54gene unveils world-class scientific research laboratory in Lagos State, Nigeria

54gene has unveiled its new lab in Lagos State, Nigeria, capable of human whole genome sequencing and a variety of other scientific investigations. Hosting a suite of world-class molecular genomics capabilities, including the Illumina Novaseq 6000 and NextSeq 550Dx the lab is part of 54gene’s mission to enable Africans to conduct genomics research and will […]

Illumina collaborates with 54gene in the creation of a world-class genomics facility in Nigeria

54gene-Illumina team

Partnership will expand 54gene’s sequencing-based research and molecular diagnostics  capabilities with a focus on improving health outcomes through precision medicine 03 September, 2020,  Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration with  54gene, a health technology company whose mission is to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics and clinical programs. The […]